Literature DB >> 30391766

Selective Shunt Occlusion of Direct Carotid-Cavernous Fistula with Vascular Ehlers-Danlos Syndrome by Multidevice Technique: A Case Report and Technical Note.

Yoshiro Ito1, Tetsu Satow2, Hirofumi Matsubara2, Hiroharu Kataoka2, Jun C Takahashi2.   

Abstract

BACKGROUND: Vascular Ehlers-Danlos syndrome (vEDS) is a vascular disease associated with a genetic collagen abnormality. It is characterized by vessel fragility, vessel rupture, and massive hemorrhage. Carotid-cavernous fistula (CCF) is the most frequent neurovascular complication of vEDS. However, CCF treatment using conventional diagnostic angiography and neuroendovascular therapy can result in a high rate of major complications. CASE DESCRIPTION: We report a case of a right CCF in a 48-year-old man with vEDS. The carotid artery and jugular vein were exposed by direct neck dissection. To avoid systemic vascular complications, multiple catheters were inserted into the shunt segment via the carotid artery and jugular vein. This transarterial and transvenous multidevice technique enabled compact placement of coils in the shunt segment. The CCF was eliminated via selective shunt occlusion. Postoperative magnetic resonance imaging revealed occlusion of the right CCF.
CONCLUSIONS: Selective shunt occlusion via a transarterial and transvenous multidevice technique is a useful and safe approach for treating vEDS-associated CCF.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Direct carotid-cavernous fistula; Multidevice technique; Selective shunt occlusion; Vascular Ehlers-Danlos syndrome

Mesh:

Year:  2018        PMID: 30391766     DOI: 10.1016/j.wneu.2018.10.158

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  Clinical classification and individualized design for the treatment of basicranial artery injuries.

Authors:  Hua Yang; Sheng-Gang Li; Xin Xiang; Ying Lv; Liang-Zhao Chu; Han Peng; Fan Wang; Han Cao; Jian Liu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.